Europe Syndromic Multiplex Diagnostic Market is growing due to prevalence of infection diseases, increasing regulatory approval for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing, growing adoption of molecular diagnostics and increasing demand for accurate and fast diagnostic results are the major drivers propelling the demand of the syndromic multiplex diagnostic market in the forecast period. However, the high cost of diagnostic products and explicit limitation of syndromic multiplex diagnostic are expected to hamper the syndromic multiplex diagnostic market growth in the forecast period.
Europe Syndromic Multiplex Diagnostic Market Scenario
According to Data Bridge Market Research the market for syndromic multiplex diagnostic, BioFire Diagnostics has the largest market share of approximately 20% to 25%. In recent time, BioFire Diagnostics (A Subsidiary of biomérieux SA) announced that they have received FDA Emergency use authorization for the BIOFIRE RP2.1 panel, which includes 22 pathogens that cause respiratory infections, including SARSCoV-2 for COVID-19 disease. After this announcement, the company has enhanced their credibility in the market.
The company operates in different brands and they are medical brands and consumer brands. The company is taking various strategic decisions to enhance its business in the market.
- In April 2018, BioFire Diagnostics (A Subsidiary of biomérieux SA) announced that they have received FDA 510 (K) clearance of the BIOFIRE FILMARRY pheumonia panel. After getting approval, the company commercialized their product into the market and generated adequate revenue.
Trends Impacting the Market
Now the question is which are the other regions BioFire Diagnostic, Siemens Healthcare GmBh, F. Hoffman La Roche Ltd are targeting? Data Bridge Market Research has forecasted a large growth in Europe syndromic multiplex diagnostic market and the market leaders are targeting U.K., Germany and France to be their next revenue pockets for 2020
Europe syndromic multiplex diagnostic market is becoming more competitive every year with companies such as BioFire Diagnostic, Siemens Healthcare GmBh, F. Hoffman La Roche Ltd act as they are the market leaders for yndromic multiplex diagnostic. Data Bridge Market Research new reports highlight the major growth factors and opportunities in the syndromic multiplex diagnostic market.
For more analysis on the Europe syndromic multiplex diagnostic market request for a briefing with our analysts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=europe-syndromic-multiplex-diagnostic-market
Europe Syndromic Multiplex Diagnostic Market Development
- In April 2020, BD announced that they have received the U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) approval for their additional molecular diagnostic test for COVID-19. The new test also received CE marked approval to the IVD Directive (98/79/EC). After this announcement, the company has enhanced their credibility in the market.
Scope of the Europe Syndromic Multiplex Diagnostic market
All analysis of the syndromic multiplex diagnostic market is further analyzed based on maximum granularity into further segmentation. On the basis of products and services, the market is segmented into reagents & consumables, instruments & accessories and software & services. On the basis of infection type, the market is segmented into viral, bacterial, parasites, fungal and others. On the basis of panels type, the market is segmented into respiratory panel, Gi-enteric panel, sexually transmitted disease panel, blood-sepsis panel, meningitis panel and others. On the basis of end user, the market is segmented into clinical laboratories, hospitals, pharmaceutical & biotechnology companies, research institutes, physician office lab's and others.
To know more about the study https://www.databridgemarketresearch.com/reports/europe-syndromic-multiplex-diagnostic-market
Key Pointers Covered in Europe Syndromic Multiplex Diagnostic Market Industry Trends and Forecast to 2027
- Market Size
- Top to Bottom Market Analysis
- Recent Developments for Market Competitors
- Recent Market Value for Different Countries
- Market value and over view of warts treatment market
- Company profiling of players of Europe Syndromic Multiplex Diagnostic care market
Key Market Competitors Covered in the Report
- GenMark Diagnostics, Inc.
- QuantuMDx Group Ltd.
- BioFire Diagnostics (a subsidiary of bioMérieux SA)
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific Inc.
- Siemens Healthcare GmbH
- QIAGEN
- Hologic, Inc.
- F. Hoffmann-La Roche Ltd
- BD
- Danaher
- Curetis
- Abbott
- DiaSorin S.p.A.
- Bosch Healthcare Solutions GmbH (a subsidiary of Robert Bosch GmbH)
- Biocartis, Luminex Corporation
- Seegene Inc.
Above are the key players covered in the report, to know about more and exhaustive list of syndromic multiplex diagnostic companies’, contact us https://www.databridgemarketresearch.com/toc/?dbmr=europe-syndromic-multiplex-diagnostic-market
Research Methodology: Europe Syndromic Multiplex Diagnostic Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Primary Respondents
- Demand Side: Dermatologists, Doctors, Healthcare Professionals
- Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.
Related Reports
Browse in Healthcare Category Related Reports@ https://www.databridgemarketresearch.com/report-category/healthcare/
CHOOSE LICENCE TYPE
LATEST NEWS
Global Allergic Asthma Disease Market is Driven by the High Prevalence of Indoor as Well as Outdoor Allergen
Global Perfume Market is Expected to Reach a Valuation of USD 44.54 Billion by 2027
Global Osteoarthritis Treatment Market is Driven by the Introduction of Novel Therapy and Promising Pipeline Drugs
Global Integrated Platform as a Service (IPaaS) Market is Driven by the Need of Organizations to Streamline Business Processes
Global Gastrointestinal Endoscopy Market is Expected to Reach a Valuation of USD 5.3 Billion by 2027
VIEW ALL
Client Associated With Us